Send to:

Choose Destination
See comment in PubMed Commons below
J Child Adolesc Psychopharmacol. 2001 Fall;11(3):289-93.

Long-term remission of schizophrenia in an adolescent treated with quetiapine.

Author information

  • 1Department of Psychiatry, New York University School of Medicine, New York 10016, USA.


The novel antipsychotic quetiapine has recently been reported to be a safe and effective treatment for adolescent psychosis in an open trial. However, there are currently no published data on its long-term tolerability and effectiveness. This report describes the successful long-term treatment of a 14-year-old girl diagnosed with schizophrenia. Continued improvement in positive symptoms was evident as long as 8 months into the treatment, and negative symptoms were still improving at 18 months. At 28 months of treatment, there were no apparent adverse effects. Long-term follow-up studies are needed to determine if the findings in this case can be generalized.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Mary Ann Liebert, Inc.
    Loading ...
    Write to the Help Desk